Announcements Trials

Browse Landscape

Status

Completed 6 Active not recruiting 3 Terminated 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 76 Carcinoma, Hepatocellular 47 Ovarian Neoplasms 40 Carcinoma, Non-Small-Cell Lung 26 Neoplasms 22 Fallopian Tube Neoplasms 17 Lung Neoplasms 15 Neoplasm Metastasis 13 Breast Neoplasms 13 Glioblastoma 12 Endometrial Neoplasms 12 Brain Neoplasms 12 Colonic Neoplasms 11 Triple Negative Breast Neoplasms 10 Rectal Neoplasms 10 Uterine Cervical Neoplasms 9 Liver Neoplasms 9 Stomach Neoplasms 8 Colorectal Cancer Metastatic 7 Pancreatic Neoplasms 6 Advanced Solid Tumors 6 Recurrence 5 Melanoma 5 Glioma 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Biliary Tract Neoplasms 5 Solid Tumor 4 Meningeal Carcinomatosis 4 Gastrointestinal Neoplasms 4

Interventions

Cisplatin 12 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Specimen Handling 10 Paclitaxel 6 Platinum 5 Cyclophosphamide 5 1,2-diaminocyclohexaneplatinum II citrate 5 fludarabine 4 durvalumab 4 cemiplimab 4 Radiotherapy, Intensity-Modulated 4 Radiotherapy 3 Pemetrexed 3 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 Cetuximab 3 Carboplatin 3 Biopsy 3 poly ICLC 2 fludarabine phosphate 2 cabozantinib 2 atezolizumab 2 Radiation 2 Ipilimumab 2 Interviews as Topic 2 Heavy Ion Radiotherapy 2 Gemcitabine 2 Drug Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma × Bevacizumab × Clear all

NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡